Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gadopiclenol pharmacokinetics in pediatric patients under 2 years
NCT05590884Phase 2Completed
- Sponsor
- Guerbet
- Start
- Sep 2022
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of gadopiclenol, sponsored by Guerbet. Started Sep 2022; status: completed.
02
Drugs
gadopiclenol
Beyond the preview
Go deeper on NCT05590884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05590884.